Analytic for Hemodynamic Instability (AHI) vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Analytic for Hemodynamic Instability (AHI)

by Fifth Eye Inc.

Reveal LINQ

by Medtronic

AI Verdict

Tool A (AHI) is an AI-driven software for in-hospital patients, predicting hemodynamic instability hours in advance using continuous ECG data to support proactive critical care. In contrast, Tool B (Reveal LINQ) is a tiny, implantable cardiac monitor that provides long-term, continuous ECG recording for up to three years to diagnose cardiac arrhythmias. Therefore, AHI is suited for acute, predictive decision support in critical settings, while Reveal LINQ is designed for extended diagnostic monitoring of heart rhythm disorders.

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose AHI if your primary need is real-time, proactive identification of hemodynamic instability in acutely ill, in-hospital adult patients. This tool is ideal for critical care settings where early warnings, hours before traditional vital signs indicate deterioration, can enable timely intervention and potentially improve patient outcomes by reducing nurse surveillance burden.

View Analytic for Hemodynamic Instability (AHI) →

Choose Reveal LINQ if…

Choose Reveal LINQ if you require long-term, continuous ECG monitoring for the diagnosis of intermittent or elusive cardiac arrhythmias in an outpatient setting. This implantable device is best suited for patients experiencing symptoms like unexplained syncope or suspected atrial fibrillation, where extended monitoring (up to three years) is necessary to capture infrequent events and aid in definitive diagnosis.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Analytic for Hemodynamic Instability (AHI)	Reveal LINQ
Deployment	Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Analytic for Hemodynamic Instability (AHI)

Tool A, as a Software as a Medical Device (SaMD) accessible via any browser-enabled device, offers a more straightforward and immediately usable interface for clinicians. Its easy-to-interpret visual indicators and design to reduce nurse surveillance burden streamline daily workflow compared to managing an implantable device system.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

Both tools offer significant clinical value, but Tool A's ability to predict hemodynamic instability hours ahead of traditional vital signs provides a critical, proactive intervention capability in acute care settings. This early warning for a life-threatening condition can significantly impact patient outcomes by enabling timely clinical action.

Pricing & Value

Reveal LINQ

While both require contacting the vendor for pricing, Tool B explicitly states that its pricing is typically integrated into procedure costs and often covered by insurance. This established financial pathway within healthcare systems may offer a more predictable and manageable cost structure for providers compared to Tool A, whose pricing model is not specified.

Enterprise Readiness

Tie

Tool A demonstrates strong enterprise readiness through its integration with existing in-hospital monitoring platforms and browser-based accessibility, simplifying IT deployment. However, Tool B benefits from Medtronic's established global presence, explicit HIPAA compliance, and extensive experience in deploying and supporting complex medical devices within large healthcare organizations.

Innovation

Analytic for Hemodynamic Instability (AHI)

Tool A's AI-driven capability to predict hemodynamic instability up to 26 hours earlier than traditional vital signs represents a significant innovation in proactive critical care management. This predictive power, based on continuous ECG data, offers a new paradigm for early intervention.

Support & Docs

Reveal LINQ

Tool B, being a product of Medtronic, a global leader in medical devices, inherently benefits from extensive and well-established support infrastructure, comprehensive documentation, and training programs. This level of enterprise-grade support and resources is typically more robust than what a smaller company like Fifth Eye (Tool A) can offer.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Analytic for Hemodynamic Instability (AHI)	Reveal LINQ
Name	Analytic for Hemodynamic Instability (AHI)	Reveal LINQ
Company	Fifth Eye	Medtronic
Description	Fifth Eye's AHI System is an FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs.	Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
Key Functionality	Predicts hemodynamic instability earlier than vital signs (up to 26 hours for AHI-PI) using continuous ECG lead II data.	Continuous ECG monitoring for up to three years with AI algorithms for detecting cardiac arrhythmias.
Categories	Cardiology AI, Triage & ER/ICU AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Critical Care, Emergency Medicine	Cardiology, Neurology

Videos

Demos, reviews, and walkthroughs featuring Analytic for Hemodynamic Instability (AHI) and Reveal LINQ.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical problem each tool is designed to address?

Tool A, Analytic for Hemodynamic Instability (AHI), is designed to continuously monitor adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs. Tool B, Reveal LINQ, is an implantable cardiac monitor that continuously records ECG to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.

How do the monitoring methods and patient populations differ between AHI and Reveal LINQ?

AHI is a Software as a Medical Device (SaMD) that integrates into in-hospital monitoring platforms, using continuous ECG lead II data for adult in-hospital patients. Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, suitable for patients requiring long-term monitoring for cardiac arrhythmias.

What type of data input do these tools use and how do their AI algorithms function?

AHI utilizes continuous ECG lead II data from existing in-hospital monitoring platforms and employs AI-driven and machine learning-based technology to predict hemodynamic instability. Reveal LINQ records continuous ECG via an implanted device and uses AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias while reducing false alerts for AF and pause.

What are the key outputs or actionable insights provided by each tool to clinicians?

AHI provides easy-to-interpret visual indicators (red, yellow, green) as early warnings for hemodynamic instability, aiming for proactive patient care. Reveal LINQ offers automatic and patient-activated event recording of ECG data, which is transmitted wirelessly for clinician review to aid in the diagnosis of cardiac arrhythmias.

How do these tools integrate into the existing clinical workflow or patient management systems?

AHI is a SaMD accessible via any browser-enabled device, integrating with existing in-hospital monitoring platforms to reduce nurse surveillance burden and streamline workflow. Reveal LINQ is an implantable device that transmits data wirelessly to the CareLinku2122 network via a bedside patient monitor, with a mobile app for clinician device management.

What are the primary benefits each tool offers in terms of patient care or operational efficiency?

AHI aims to provide proactive patient care by predicting hemodynamic instability earlier than vital signs, thereby reducing nurse surveillance burden. Reveal LINQ offers continuous, long-term ECG monitoring with AI-powered accuracy to reduce false alerts, facilitating the accurate diagnosis of cardiac arrhythmias and potentially preventing related adverse events.